Latest CellTherapy News and Updates : CellTherapy updates, CellTherapy News , CellTherapy around the world

Nishadil

Washington | 20°C (overcast clouds)

A New Dawn for Aching Knees: MediPost's CARTISTEM Delivers Breakthrough Results in Japan

Top story

A New Dawn for Aching Knees: MediPost's CARTISTEM Delivers Breakthrough Results in Japan

In focus

Latest feed

Imagine a Future: One Tiny Implant, Multiple Treatments for HIV, Obesity, and More

Sana Biotechnology: A Deep Dive into a Speculative Biotech Bet

Bristol Myers Squibb Announces Significant Operational Shift in Devens, Leading to Job Losses

Vericel's Growth Story: Is the Tank Running on Empty?

Latest headlines

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

Sangamo Therapeutics Sees Shares Surge as FDA Grants Fast Track for Landmark Transplant Rejection Therapy

Sangamo Therapeutics Sees Shares Surge as FDA Grants Fast Track for Landmark Transplant Rejection Therapy

Quantum Leap for Life Sciences: IonQ and CCRM Team Up to Revolutionize Biotech and Medicine

Quantum Leap for Life Sciences: IonQ and CCRM Team Up to Revolutionize Biotech and Medicine

Cabaletta Bio's Q3 Unveils a Story of Progress and Promise in Autoimmune Therapies

Cabaletta Bio's Q3 Unveils a Story of Progress and Promise in Autoimmune Therapies

The Biotech Crossroads: Where Vor Biopharma and Liminatus Pharma Stand in the Race for Innovation

The Biotech Crossroads: Where Vor Biopharma and Liminatus Pharma Stand in the Race for Innovation

Beyond the Horizon: The Enduring Promise of CAR T-Cell Therapy for Myeloma

Beyond the Horizon: The Enduring Promise of CAR T-Cell Therapy for Myeloma

CAR-T's Tightrope Walk: Why Autolus Faces an Uphill Battle Despite a Breakthrough

CAR-T's Tightrope Walk: Why Autolus Faces an Uphill Battle Despite a Breakthrough

Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

Beyond the Horizon: Manipal's Groundbreaking Conclave Illuminates Cell Therapy's Potential

Beyond the Horizon: Manipal's Groundbreaking Conclave Illuminates Cell Therapy's Potential

The Quiet Revolution: Unpacking the Billions Behind Biotech's Essential Cell Banks

The Quiet Revolution: Unpacking the Billions Behind Biotech's Essential Cell Banks

Immatics Unveils Groundbreaking Anzu-cel Data: A New Dawn for Metastatic Uveal Melanoma Patients at ESMO 2025

Immatics Unveils Groundbreaking Anzu-cel Data: A New Dawn for Metastatic Uveal Melanoma Patients at ESMO 2025

Sana Biotech Skyrockets: Eric Jackson's Bold Endorsement Fuels 50% Surge

Sana Biotech Skyrockets: Eric Jackson's Bold Endorsement Fuels 50% Surge

Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors

Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors

Unlocking Tomorrow's Cures: Bristol Myers Squibb's Daring Dive into Next-Gen Autoimmune Cell Therapies

Unlocking Tomorrow's Cures: Bristol Myers Squibb's Daring Dive into Next-Gen Autoimmune Cell Therapies

Unlocking the Future of Medicine: Scientists Tackle Immune Rejection in Stem Cell Therapy

Unlocking the Future of Medicine: Scientists Tackle Immune Rejection in Stem Cell Therapy

A New Dawn for Medicine: Florida Engineers Dramatically Scale Up Extracellular Vesicle Production

A New Dawn for Medicine: Florida Engineers Dramatically Scale Up Extracellular Vesicle Production

Revolutionizing Healthcare: The Exploding Exosome, Cell, and Gene Therapy Market

Revolutionizing Healthcare: The Exploding Exosome, Cell, and Gene Therapy Market

Revolutionizing Medicine: Tiny Genetic Switches Promise Safer, Smarter Therapies

Revolutionizing Medicine: Tiny Genetic Switches Promise Safer, Smarter Therapies

A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy

A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy

Brainstorm Cell Therapeutics Unveils Robust Q2 2025 Financials and Pivotal Clinical Advancements

Brainstorm Cell Therapeutics Unveils Robust Q2 2025 Financials and Pivotal Clinical Advancements

Load more